Evidence map›Paper›PMID 31408497›Full record

ArticlePloS one2019

Application of mini-MLST and whole genome sequencing in low diversity hospital extended-spectrum beta-lactamase producing Klebsiella pneumoniae population.

Matej Bezdicek, Marketa Nykrynova, Kristina Plevova, Eva Brhelova, Iva Kocmanova, Karel Sedlar, Zdenek Racil, Jiri Mayer, Martina Lengerova

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Matej BezdicekDepartment of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.ORCID 0000-0002-5833-8325
Marketa NykrynovaDepartment of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
Kristina PlevovaDepartment of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
Eva BrhelovaDepartment of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
Iva KocmanovaDepartment of Clinical Microbiology, University Hospital Brno, Brno, Czech Republic.
Karel SedlarDepartment of Biomedical Engineering, Brno University of Technology, Brno, Czech Republic.
Zdenek RacilDepartment of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
Jiri MayerDepartment of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
Martina LengerovaDepartment of Internal Medicine-Hematology and Oncology, University Hospital Brno, Brno, Czech Republic.
Masaryk University · CZUniversity Hospital Brno · CZBrno University of Technology · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Studying bacterial population diversity is important to understand healthcare associated infections' epidemiology and has a significant impact on dealing with multidrug resistant bacterial outbreaks. We characterised the extended-spectrum beta-lactamase producing K. pneumoniae (ESBLp KPN) population in our hospital using mini-MLST. Then we used whole genome sequencing (WGS) to compare selected isolates belonging to the most prevalent melting types (MelTs) and the colonization/infection pair isolates collected from one patient to study the ESBLp KPN population's genetic diversity. A total of 922 ESBLp KPN isolates collected between 7/2016 and 5/2018 were divided into 38 MelTs using mini-MLST with only 6 MelTs forming 82.8% of all isolates. For WGS, 14 isolates from the most prominent MelTs collected in the monitored period and 10 isolates belonging to the same MelTs collected in our hospital in 2014 were randomly selected. Resistome, virulome and ST were MelT specific and stable over time. A maximum of 23 SNV per core genome and 58 SNV per core and accessory genome were found. To determine the SNV relatedness cut-off values, 22 isolates representing colonization/infection pair samples obtained from 11 different patients were analysed by WGS with a maximum of 22 SNV in the core genome and 40 SNV in the core and accessory genome within pairs. The mini-MLST showed its potential for real-time epidemiology in clinical practice. However, for outbreak evaluation in a low diversity bacterial population, mini-MLST should be combined with more sensitive methods like WGS. Our findings showed there were only minimal differences within the core and accessory genome in the low diversity hospital population and gene based SNV analysis does not have enough discriminatory power to differentiate isolate relatedness. Thus, intergenic regions and mobile elements should be incorporated into the analysis scheme to increase discriminatory power.

Indexed as

Drug Resistance, Multiple, BacterialMultilocus Sequence TypingWhole Genome SequencingAdolescentAdultAgedAged, 80 and overBacterial Proteinsbeta-LactamasesChildChild, PreschoolCross InfectionDNA, BacterialFemaleHumansInfantBacterial Proteinsbeta-LactamasesDNA, Bacterial

Identifiers

PMID31408497
PMCPMC6692064
OpenAlexW2968302266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.